France· FR:62639275
OLANZAPINE VIATRIS 20 mg, comprimé orodispersible
A olanzapine product containing olanzapine, registered in France by VIATRIS SANTE. The same ATC class is registered in 18 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Olanzapine is registered in 18 of 19 countries.
Countries holding a registration under ATC N05AH03 (olanzapine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Olanzapine · ATC N05AH03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of olanzapine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.17 in United States to $3.34 in Switzerland — a ×19 gap.
- France: $0.63 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Olanzapine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$3.34
- IT Italy$1.59
- FR France$0.63
- US United States$0.17 (acquisition cost)
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OLANZAPINE
- Manufacturer
- VIATRIS SANTE
- Country
- France (FR)
- ATC code
- N05AH03
- ATC class
- Olanzapine
- Defined daily dose
- 10 mg, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340092760519228 plaquette(s) polyamide aluminium PVC de 1 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
481 interactions on record for olanzapine.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olanzapine · interactions on record
481 records
- 14 severe
- 292 moderate
- 3 minor
- 137 info
Most severe, free to view
- MetoclopramideA03FA01severe
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
35 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Olanzapine in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandArkolamylMylan AB
- United KingdomArkolamyl 20mg orodispersible tabletsViatris UK Healthcare Ltd
- United StatesolanzapineBionpharma Inc.
- PolandAnzorinOrion Corporation
- SpainARENBIL FLAS 20 mg COMPRIMIDOS BUCODISPERSABLES EFGNeuraxpharm Spain S.L.U.
- BelgiumOlanzapine AB 20 mgAurobindo
- CanadaAPO-OLANZAPINE ODTAPOTEX INC
- IrelandOlanzapine 20mg Orodispersible TabletsAccord Healthcare Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Aedon, Olanzapin +pharma
- Belgium · Olanzapine, Olanzapine Ab
- Bulgaria · Oлфрекс, Еголанза
- Cyprus · Bloonis, Lapozan
- Czechia · Egolanza, Nykob
- Germany · Olanzapin 1 A Pharma, Olanzapin Abz
- Denmark · Farpenta, Kynapine Odt
- Estonia · Farpenta, Olanzapin Actavis
- Spain · Arenbil, Arenbil Flas
- Finland · Olanzapin Orion, Olanzapin Ratiopharm
- United Kingdom (Northern Ireland) · Olanzapine Accord, Olanzapine Bristol Laboratories
- Greece · Bloonis, Caprilon Od
- Croatia · Olandix, Olanzalux
- Hungary · Egolanza, Olpinat
- Ireland · Olanzapine Accord, Olanzapine Accord Healthcare Ireland
- Iceland · Olanzapin Actavis, Olanzapine Teva
- Italy · Farpenta, Lazapir
- Liechtenstein · Olanzapine Teva, Olanzapine Viatris
- Lithuania · Olanzapin Actavis, Olanzapine Accord
- Luxembourg · Olanzapine Eg, Olanzapine Instant Eg
- Latvia · Olanzapine Accord
- Malta · Olancer, Olanzapine Aurobindo
- Netherlands · Olanzapine Accord, Olanzapine Aurobindo
- Norway · Olanzapine Accord, Olanzapine Teva
- Poland · Egolanza, Olanzapina Viatris
- Portugal · Olanzapina Alter, Olanzapina Aurobindo
- Romania · Olanzapină Arena, Olanzapina Aurobindo
- Sweden · Olanzapin Actavis, Olanzapin Sandoz
- Slovenia · Zolrix
- Slovakia · Olanzapin Actavis, Olanzapin Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac366a4d-6829-4c58-a60c-781d9507dcb0 GET /v1/drugs/ac366a4d-6829-4c58-a60c-781d9507dcb0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62639275",
"date_amm": "2015-03-25",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "OLANZAPINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé orodispersible",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about olanzapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.